BNET Industries
cardinal health inc. - All News and Analysis
Cardinal Health Inc. F1Q09 (Qtr. End 09/30/08) Earnings Conference Call Transcript
Question-and-Answer Session[Operator Instructions]. And the first question comes from the line of Tom Gallucci from Merrill Lynch. Please proceed. Tom Gallucci - Merrill Lynch Good morning. Thank you very much. I had one each, hopefully for Dave and for George. Dave, just wondering you gave some steps there in...
Earnings Preview: Cardinal Health
Cardinal Health CAH is expected to report Q1 earnings before market open Wednesday Oct. 28 with a conference call scheduled for 8:30 am. Guidance Analysts are looking for a profit of 70c on revenue of $22.86B. The consensus is 70c to 73c for EPS, and $22.23B to $23.23B for revenue,...
Healthcare Roundup: Revolution Health Vanishes, Cardinal Health Penalized, and More
Revolution Health merges with Waterfront Media in $300M deal -- So the rumors were true. Steve Case's once-flashy startup, Revolution Health Network, agreed last week to merge with Waterfront Media, owner of several online-health Web sites, in a $300 million deal. Case will continue to run Revolution LLC, which will...
Healthcare Roundup: Cardinal Health Spinoff, Hospitals Ditch Debt, and More
Cardinal Health to spin off clinical, medical-product units -- The healthcare-services company said it will form a new $4 billion spinoff firm from units that handle distribution of surgical and medical products. Cardinal will retain drug and medical-supply chain services under its own roof. [Source: Health Data Management] ...
Cardinal Health, Inc. F4Q08 (Qtr. End 06/30/08) Earnings Call Transcript
Question-and-Answer Session[Operator Instructions] Our first question comes from the line of Glen Santangelo for Credit Suisse. Please proceed. Glen Santangelo - Credit Suisse Yeah thanks. I just had a quick question, on the drug distribution George, could you help me understand, it sounds like the DEA issue it seems...
Earnings Preview: Cardinal Health
Cardinal Health CAH is expected to report Q4 earnings before market open Thursday, Aug. 7, with a conference call scheduled for 8:30 am ET. Guidance Analysts are looking for a profit of 95c on revenue of $23.17B. The consensus is 93c to $1.00 for EPS, and $23.04B to $23.42B for...
Syntermed Announces New Products and Agreements at Society of Nuclear Medicine Annual Meeting
Company Unveils First Commercially Available Clinical Software Imaging Tools that can - Assist with the Differential diagnosis of dementia in early stages Predict before surgery whether epilepsy patients will be seizure-free after surgery Identify heart failure patients who can benefit from cardiac resynchronization therapy GE Healthcare,...
Fitch Rates Cardinal Health's $300MM Sr Unsec Notes Offering 'BBB+'
CHICAGO -- Fitch has assigned a 'BBB+' rating to Cardinal Health's (NYSE: CAH) $300 million senior unsecured notes offering. This is a SEC registered offering. The company intends to use the proceeds from the issuance for general corporate purposes, which may include repayment of indebtedness, working capital, capital expenditures, acquisitions,...
Research and Markets: Cardinal Health Medical Device Company Intelligence Report Available Now
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c91428) has announced the addition of "Cardinal Health Medical Device Company Intelligence Report" to their offering.
Cardinal Health Completes Enturia Acquisition
ChloraPrepR Products Expand Infection Prevention Business
Cardinal Health, Inc. F3Q08 (Qtr. End 03/31/08) Earnings Call Transcript
Question-and-Answer Session[Operator Instructions]. Our first question comes from the line of Lisa Gill from JPMorgan. Please proceed. Atif Rahim - JPMorgan Hi Thanks its Atif Rahim in for Lisa. I think we just have a couple of questions on distribution margins. I know George you just commented that the...
Medical Institutional Services Holdings Finalized Agreements With Cardinal Health
Medical Institutional Services Holdings Inc. MIHS (PINKSHEETS: MIHS) has finalized financial and supplier contracts with Cardinal Health, one of the nation's leading manufacturers of medical supplies. Cardinal, whose revenues exceed $87 billion dollars, provides the industry with the finest and most current technology available in the world. "We are very...
Fitch Affirms Cardinal Health's IDR at 'BBB+'; Outlook Stable
CHICAGO -- Fitch has affirmed the following ratings for Cardinal Health CAH.
NANOSCIENCE INC - Final Results.(Company overview)
Embargoed Release: 07:00hrs Thursday 20 March 2008 Nanoscience Inc. ...
New York Strengthens Emergency Preparedness with Cardinal Health Ventilators
To: HEALTH EDITORS To: HEALTH EDITORS
Cardinal Health.(Technology Solutions: Surgical Equipment Repair Services)
Part of Cardinal Health, OnSite[SM] Services focuses on instruments so hospitals can focus on patient care. The OnSite Services inventory management program offers instrument procurement, standardization and set optimization as well as education on t Part of Cardinal Health, OnSite[SM] Services focuses on instruments so...
Cardinal Health, Inc. F2Q08 (Qtr. End 12/31/07) Earnings Call Transcript
Question-and-Answer Session[Operator Instructions]. Your first question comes from the line of Glen Santangelo from Credit Suisse. Please proceed. Glen Santangelo - Credit Suisse First Boston Yes Kerry, just a couple of quick questions on the drug distribution business. You said earlier in the call, you renegotiated the CVS business...
Research and Markets: Cardinal Health Inc. is Analyzed in Relation to Its Value Chain Positioning and Strategic Strengths and Weaknesses
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79801) has announced the addition of "Cardinal Health, Inc. Strategic Analysis Profile" to their offering.
Zacks Sell List Highlights: HSBC Holdings, Lowe's Companies, Cardinal Health and News Corp
CHICAGO -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List - Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 Strong Sell: HSBC Holdings (NYSE: HBC) and Lowe's Companies, Inc. (NYSE: LOW). Further, Zacks...
Largest construction projects: ranked by contract amount
LARGEST CONSTRUCTION PROJECTS Ranked by contract amount Project name * Contract amount Rank Project address * General contractor...
Sort byClose
View by Content TypeClose
View by Related Tag Close
- Finance (20 results)
- Healthcare (19 results)
- stock (17 results)
- agreement (14 results)
- Software (13 results)
- Benefits (12 results)
- Columbus (12 results)
- Health Care (11 results)
- Investment (11 results)
- company (10 results)
- SEC (10 results)
- Patient (9 results)
- Fitch (9 results)
- New York Stock Exchange (7 results)
- SALES (7 results)
- pharmaceutical company (6 results)
- biotechnology (6 results)
- industry (6 results)
- acquisition (5 results)
- S&P 500 (5 results)
- class action (5 results)
- manufacturing (4 results)
- Earnings (4 results)
- Hospital (4 results)
- glove (4 results)
- Business Wire (4 results)
- Eli Lilly & Co. (3 results)
- Internet (3 results)
- Kimberly-Clark Corp. (3 results)
- job (3 results)
- Microsoft Outlook (3 results)
- Enterprise Software (3 results)
- Boston Globe (3 results)
- board (3 results)
- performance (3 results)
- Strategy (3 results)
- accounting (3 results)
- MARKETING (3 results)
- Revenue (Fiscal Year) $91.0B
- Profit (Fiscal Year) $1.3B
- Incorporated: 1982
- CEO: Mr. R. Kerry Clark
Cardinal Health is a provider of products and services for the healthcare industry. Co. has four segments: Healthcare Supply Chain Services - Pharmaceutical, which distributes branded and generic pharmaceutical products, over-the-counter healthcare products and consumer products; Healthcare Supply Chain Services - Medical, which distributes branded and private-label medical and laboratory products, as well as Co.'s own line of surgical and respiratory therapy products; Clinical Technologies and Services, which provides products and services to hospitals and other healthcare providers; and Medical Products and Technologies, which develops and manufactures medical and surgical products.
Competitors
Stock Quote
Board of Directors
Mr. R. Kerry Clark Chairman
Mr. Michael D. O'Halleran
Mr. David W. Raisbeck
Dr. Jean G. Spaulding M.D.
Ms. Colleen F. Arnold
Mr. Calvin Darden
Mr. John F. Finn
Mr. Philip L. Francis
Mr. Gregory B. Kenny
Mr. J. Michael Losh
Mr. John B. McCoy MBA
Mr. Richard C. Notebaert
NAICS Code
Drugs and Druggists' Sundries Merchant Wholesalers: 424210
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 06, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Dec 16, 2008about WNI
-
AVANIR Pharmaceuticals F4Q08 (Qtr End 10/31/08) Earnings Call Transcript
on Dec 15, 2008about AVNR
-
Martek Biosciences Corporation F4Q08 (Qtr End 10/31/08) Earnings Call Transcript
on Dec 11, 2008about MATK
-
Peregrine Pharmaceuticals F2Q09 (Qtr End 10/31//08) Earnings Call Transcript
on Dec 10, 2008about PPHM